![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, June 04, 2019 9:16:58 AM
In another words another countdown as was experienced with the 15-Jan PR pump is being projected?
Only problem is the 15-Jan PR pump had Kenny watching the cells growing. By definition at least day 12 of the process. Now go back and look at the 03-Jun PR pump...
It's "underway" - as in raw materials being shipped into the AN lab? What exactly does the word "underway" mean? Then we have:
Mr. Waggoner and Mr. Judd will observe the culturing
Where in the PR does it state Kenny and his new pal have arrived, and are actually onsite. As in already observing the culturing? Earlier we have the phrase:
Chief Executive Officer, Kenneth L. Waggoner, and PharmaCyte’s consultant cellular biologist, David Judd, will be on site
You don't say "will be" if you are already there.
So are they going to arrive on site tomorrow, or whenever? There's no reason any Jan like countdown should have already began.
Finally we have the biggy:
this time two manufacturing runs will be performed in a staggered fashion
Compare to the 18-Sep-18 PR pump:
The decision to regard the run as an engineering run before the final production run
Note the latest Jun PR pump says "manufacturing" not "production". Either Kenny has changed his terminology again, or these two staggered manufacturing runs are not the final production run. And why suddenly do you need two manufacturing runs in order to equal "one" final production run?
If one wants to believes these two staggered manufacturing runs constitutes 1 production run, then there's still no timeline. No evidence the first has started. Instead of a 28 day cycle back in Jan, one now has a 22 day cycle. So do they start the 2nd run 22 days later than the current undefined start of the 1st? Wait another 30 days for the QC, before starting the 2nd run? Longer than that?
IMO, your 2 months could easily become a scenario where it takes months just to make the 1st run. Possibly by August the 2nd run is occurring. Then months later Kenny announces they are performing some more cell tweaking. Due to something not quite "perfect". In any case Kenny will make it a countdown to nothing.
PPS at 10 cents prior to IND
He'll need some spiffy paid promos. Because currently there is retail investor exhaustion, having gulped down 1.2B+ shares already. Kenny needs new retail investors, and whether enough show up to support a 0.01 gain is problematic. Any spike beyond that will be short lived, as insiders dump into it.
I will say I have no faith in this management to do that
I have faith Kenny will continue to do as he has in the past. Keep recycling PR pumps.
The Jewel of the Mind is Colored with the Hue of what it Imagines
Recent PMCB News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:05:04 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/30/2024 08:05:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:40:20 PM
- PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease • Business Wire • 05/21/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:56:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 10:25:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:00:10 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/22/2023 09:00:15 PM
- PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. • Business Wire • 11/15/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:25:09 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/21/2023 09:04:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/18/2023 10:04:06 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 09/15/2023 09:00:03 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/12/2023 01:56:25 AM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM